期刊文献+

支气管肺泡灌洗液中3种肿瘤标志物的含量检测及意义 被引量:2

Clinical significance of determination of 3 tumor markers in bronchoalveolar lavage fluid
暂未订购
导出
摘要 目的:研究支气管肺泡灌洗液(BALF)中3种肿瘤标志物癌胚抗原(CEA)、细胞角蛋白片段21-1(CYFRA21-1)、组织多肽特异性抗原(TPS)对肺癌的临床诊断意义.方法:采用电化学发光免疫分析仪法(Elecys2010)、酶联免疫吸附法分别检测62例肺癌患者、36例肺部良性病变患者血清及BALF中CEA和CYFRA21-1,TPS的含量.结果:肺癌患者BALF中3种肿瘤标志物的含量明显高于肺部良性病变患者(P<0.05),且随着TNM临床分期升高,肿瘤标志物的含量也明显升高.在不同病理类型的肺癌中,3种肺癌肿瘤标志物升高的程度均有所不同.BALF中肿瘤标志物的含量与同期血清中的含量相比,出现更早且浓度更高,尤以TPS升高最为明显.结论:BALF中3种肺癌标志物的检测在肺癌的早期诊断、病理类型的推断及预后判断方面都有一定的意义,其临床价值优于血清. AIM: To investigate the clinical value of 3 tumor markers [ carcinoembryonic antigen (CEA), cytokeratin-19-fragments (CYFRA21-1) and tissue polypeptide specific antigen (TPS) ] in bronchoalveolar lavage fluid (BALF) in patients with lung cancer. METHODS: The levels of CEA, CYFRA21-1 and TPS in serum and BALF were measured in 62 patients with lung cancer and 36 patients with benign lung disease by electrochemiluminescence (Elecys2010) and ELISA respectively. RESULTS: The levels of the 3 tumor markers measured in BALF were much higher in lung cancer group than that in benign lung disease group ( P 〈0. 05) and they were higher in patients in stage Ⅲ and Ⅳ than those in stage Ⅰ and Ⅱ. The tumor markers increased to different degrees among the patients in various pathological classifications. It was also found that the levels of these tumor markers were higher and more sensitive in BALF than those in serum, especially in TPS. CONCLUSION: The measurement of the tumor markers in BALF is of more significant value than the measurement in serum, which helps the early diagnosis, pathological classification and prognosis evaluation of lung cancer.
出处 《第四军医大学学报》 CAS 北大核心 2005年第16期1499-1502,共4页 Journal of the Fourth Military Medical University
基金 陕西省二00四年科技计划项目(2004K13-G3)
关键词 肺肿瘤 支气管肺泡灌洗液 肿瘤标记 生物学 lung neoplasms bronchoalveolar lavage fluid tumor markers, biological
  • 相关文献

参考文献10

  • 1王国洪,万文徽,刘波,刘娟,张书耕,梁震,杨江颖,张晶,董大海.四种肿瘤标志检测非小细胞肺癌的临床应用研究[J].中华检验医学杂志,2003,26(8):491-494. 被引量:51
  • 2陈名声,于文彬,卢宝弼,代艳丽,刘建新.血清组织多肽特异抗原水平与肺癌生物学行为的关系[J].中华结核和呼吸杂志,2002,25(5):262-264. 被引量:21
  • 3Landis SH, Murray TM, Bolden S, et al. Cancer statistics 1999[J]. CA Cancer J Clin, 1999;49:44 -46.
  • 4Kulpa J, wojcik E, Radkowski A, et al. CYFRA21-1, TPA-M,TPS, SCC-Ag and CEA in patients with squamous cell lung cancer and in chemical industry workers as a reference group [ J]. Anticancer Res, 2000 ;20:5035 - 5040.
  • 5Sun SS, Hsieh JF, Tsai SC, et al. Tissue polypeptide specific antigen and carcinoembryonic antigen for early prediction of recurrence in Lung adenocarcinoma [ J ]. Am J Clin Oncol, 2000; 23:605 - 608.
  • 6Ho Y J, Hsieh JF, Tasi SC, et al. Tissue polypeptide specific antigen and squamous cell carcinoma antigen for early prediction of recurrence in lung squamous cell carcinoma [ J ]. Lung, 2000; 178:75 - 80.
  • 7Mitauhashi N, Takahashi T, Sakruai H, et al. Establishment and characterization of new human lung pooly differentiated adenocarcinoma cell line, GⅡ-1 producing carcinombryonic antigen (CEA)and CA19-9 [J]. Lung Cancer, 1995;12:13.
  • 8Muraki M, Tohda Y, et al. Assessment of serum Cyfra21-1 in lung cancer [ J]. Cancer, 1996 ;77:1274 - 1277.
  • 9陈锐,胡华成,胡筠珠,李建祥.支气管肺泡灌洗液中3种肿瘤标志物检测的临床价值[J].苏州大学学报(医学版),2003,23(3):336-338. 被引量:14
  • 10Pujol JL, Boher JM, Grenier J, et al. Cyfra21-1, neuron specific enolase and prognosis of non-small cell lung cancer: Propective study in 621 patients [J]. Lung Cancer, 2001 ;31:221 -231.

二级参考文献21

  • 1万文徽,李吉友.肿瘤标志的临床应用[J].中华医学检验杂志,1997,20(1):49-51. 被引量:180
  • 2Verstraeten A, Sault MC, Wallaert B, et al. Metastatic prostatic adenoearcinoma- diagnosed by bronchoalveolar lavage and tumour marker determination [ J ]. Eur Respir J, 1997, 4 : 1296.
  • 3Pina TC , Zapata IT , Hernandez FC , et al . Tumour markers in serum, bronchoalveolar lavage and biopsy cytosol in lung carcinoma: what environment lends the optimum diagnostic yield[J]? Clin Chim Acta, 2001, 305:27 -- 34.
  • 4Mitauhashi N, Takahashi T, Sakruai H, et al. Establishment and characterization of a new human lung poorly differentiated adenocarcinoma cell line, G11 - 1 producing carcinoembryonic antigen (CEA) and CA19 - 9 [J].Lung Cancer, 1995, 12:13.
  • 5Muraki M, Tohda Y, Iwanaga T, et al. Assessment of serum Cyfra21 - 1 in lung cancer[J]. Cancer, 1996, 77:1274-1277.
  • 6Quoix E, Purohit A, Falleer Beau M, et al. Comparative prognostic value of lactate dehydrogenase and neurospecific enolase in small - cell lung cancer patients treated with platinum - based chemotherapy[J ]. Lung Cancer, 2000,30:121-- 134.
  • 7Pujol JL, Boher JM, Grenier J, et al. Cyfra21 - 1, neuron specific enolase and prognosis of non - small cell lung cancer: prospective study in 621 patients[J]. Lung Cancer, 2001,31:221 --231.
  • 8Foa P, Fornier MF, Miceli R, et al . Tumour markers CEA, NSE, SCC, TPA and CYFRA21 - 1 in resectable non- small cell lung cancer[J]. Anticancer - Res, 1999,19: 3613--3618.
  • 9Ronald GC, Herbert YR , Anthony RK , et al . Bronchoalveolar lavage the report of an international conference[ J ]. Chest, 1986, 90:122--125.
  • 10Pujol JL,Grenier J,Parrat E,et al.Cytokeratins as serum markers in lung cancer: a comparison of CYFRA 21-1 and TPS[].American Journal of Respiratory and Critical Care Medicine.1996

共引文献80

同被引文献12

引证文献2

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部